Zhongmei Zhou

Zhongmei Zhou

Auto-generated profile, based on publicly available information

Zhongmei Zhou

Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2022 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
Dewei JiangDewei Jiang
Dewei Jiang
TQTing Qiu
Ting Qiu
JPJunjiang Peng
Junjiang Peng
SLSiyuan Li
Siyuan Li
TATala
Tala
Ceshi ChenCeshi Chen
Ceshi Chen

30 July 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FLFubing Li
Fubing Li
YLYang Li
Yang Li
HLHuichun Liang
Huichun Liang
TXTao Xu
Tao Xu
YKYanjie Kong
Yanjie Kong
XQXiaopeng Qi
Xiaopeng Qi
Lysine-63–linked (K63-linked) polyubiquitination of TRAF3 coordinates the engagement of pattern-recognition receptors with recruited adaptor proteins and downstream activator TBK1 in pathways that induce type I IFN. Whether autoubiquitination or other E3 ligases mediate K63-linked TRAF3 polyubiquitination remains unclear. We demonstrated that mice deficient in the E3 ligase gene Hectd3 remarkably increased host defense against infection by intracellular bacteria Francisella novicida, Mycobacterium, and Listeria by limiting bacterial dissemination. In the absence of HECTD3, type I IFN response was impaired during bacterial infection both in vivo and in vitro. HECTD3 regulated type I IFN production by mediating K63-linked polyubiquitination of TRAF3 at residue K138. The catalytic domain of HECTD3 regulated TRAF3 K63 polyubiquitination, which enabled TRAF3-TBK1 complex formation. Our study offers insights into mechanisms of TRAF3 modulation and provides potential therapeutic targets against infections by intracellular bacteria and inflammatory diseases.

1 September 2021 in Cancer Letters
Verified
Journal Article
Closed access
HWHaixia Wang
Haixia Wang
YSYujie Shi
Yujie Shi
CCChuan-Huizi Chen
Chuan-Huizi Chen
YWYi Wen
Yi Wen
ZZZhongmei Zhou
Zhongmei Zhou
Ceshi ChenCeshi Chen
Ceshi Chen